Galectin Therapeutics (GALT) Non-cash Items (2012 - 2025)

Galectin Therapeutics has reported Non-cash Items for 10 years, with the latest figure at $6.2 million in Q4 2025.

• For the quarter ending Q4 2025, Non-cash Items rose 3308.47% year-over-year to $6.2 million; the trailing twelve-month figure through Dec 2025 stood at $6.2 million (up 3308.47% YoY), and the FY2025 full-year result was $6.2 million, up 3308.47% from the prior year.
• Non-cash Items for Q4 2025 stood at $6.2 million, up from $183000.0 in the prior quarter.
• The five-year high for Non-cash Items was $6.2 million in Q4 2025, with the low at $183000.0 in Q4 2024.
• Average Non-cash Items over 5 years is $2.2 million, with a median of $632000.0 recorded in 2023.
• Year-over-year, Non-cash Items slumped 82.2% in 2023 and soared 3308.47% in 2025.
• Tracing GALT's Non-cash Items over 5 years: stood at $246000.0 in 2021, then surged by 1343.66% to $3.6 million in 2022, then tumbled by 82.2% to $632000.0 in 2023, then slumped by 71.04% to $183000.0 in 2024, then soared by 3308.47% to $6.2 million in 2025.
• The last three Non-cash Items figures came in at $6.2 million (Q4 2025), $183000.0 (Q4 2024), and $632000.0 (Q4 2023), per Business Quant data.

Peer Comparison